Literature DB >> 3260873

Lymphocyte subsets in peripheral blood and pleural fluid.

G Lucivero1, G Pierucci, L Bonomo.   

Abstract

We have examined the distribution of B and T lymphocytes, T-cells with helper/inducer (T4+) or suppressor/cytotoxic (T8+) phenotypes and a subset of cells with natural killer (NK) activity and positive for the Leu 7 (HNK-1) surface antigen in peripheral blood and in lymphocyte-rich pleural effusions of patients with tuberculosis or malignancies (mesothelioma and lung cancer with pleural metastasis). In individual patients, the percentages of T lymphocytes were uniformly higher in pleural effusions than in peripheral blood; however, lower percentages of B lymphocytes and cells positive for the Leu 7 antigen were present in pleural fluids. The analysis of T-cell subpopulations demonstrated a selective enrichment of T lymphocytes with helper/inducer phenotype in pleural effusions, while the percentages of T-cells with suppressor/cytotoxic phenotype were similar in pleural fluid and peripheral blood. These results indicate that in lymphocytic pleural effusions the main lymphoid cell population is represented by T lymphocytes with helper/inducer phenotype, regardless of whether the effusion is due to tuberculosis or malignancies such as mesothelioma or lung cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3260873

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

1.  Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.

Authors:  Zhi-Jian Ye; Qiong Zhou; Rong-Hui Du; Xiao Li; Bo Huang; Huan-Zhong Shi
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

2.  Th17/Treg imbalance in malignant pleural effusion.

Authors:  Wei-Bing Yang; Zhi-Jian Ye; Fei Xiang; Jian-Chu Zhang; Qiong Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

3.  Prognostic value of CD4+ lymphocytes in pleural cavity of patients with non-small cell lung cancer.

Authors:  K Takahashi; S Saito; Y Kamamura; M Katakawa; Y Monden
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

4.  The characterization of peritoneal and pleural exudate cells from malignant effusions.

Authors:  M Oka; S Yoshino; S Hazama; K Shimoda; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  CD4(+) CD25(high) forkhead box protein 3(+) regulatory T lymphocytes suppress interferon-γ and CD107 expression in CD4(+) and CD8(+) T cells from tuberculous pleural effusions.

Authors:  L Geffner; J I Basile; N Yokobori; C Sabio Y García; R Musella; J Castagnino; M C Sasiain; S de la Barrera
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

6.  CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism.

Authors:  Zhi-Jian Ye; Qiong Zhou; Jian-Chu Zhang; Xiao Li; Cong Wu; Shou-Ming Qin; Jian-Bao Xin; Huan-Zhong Shi
Journal:  Respir Res       Date:  2011-06-10

7.  High IL-35 pleural expression in patients with tuberculous pleural effusion.

Authors:  Xuan Dong; Jiong Yang
Journal:  Med Sci Monit       Date:  2015-05-03

8.  Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.

Authors:  Arnaud Scherpereel; Bogdan Dragos Grigoriu; Marc Noppen; Thomas Gey; Bachar Chahine; Simon Baldacci; Jacques Trauet; Marie-Christine Copin; Jean-Paul Dessaint; Henri Porte; Myriam Labalette
Journal:  BMC Cancer       Date:  2013-07-02       Impact factor: 4.430

Review 9.  Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.

Authors:  Heriberto Prado-Garcia; Susana Romero-Garcia; Dolores Aguilar-Cazares; Manuel Meneses-Flores; Jose Sullivan Lopez-Gonzalez
Journal:  Clin Dev Immunol       Date:  2012-10-17

10.  Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization.

Authors:  Lucia Maria Zanatta de Aguiar; Leila Antonangelo; Francisco S Vargas; Maria Cláudia Nogueira Zerbini; Maria Mirtes Sales; David E Uip; Paulo Hilário Nascimento Saldiva
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.